Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
96 Views
Favorite
0
Like
Facebook
Tweet
Print
Email
W. Mike Heath ASHP Federal Forum
(1-083) Tolerability and Effects of Discontinuation of Glucagon-like peptide-1 receptor agonist (GLP-1 RA) and Glucagon-like peptide-1 / Gastric inhibitory polypeptide receptor agonist (GLP-1/GIP RA)
Sunday, December 8, 2024
3:30 PM – 5:00 PM
Location: Hall G, Lower Level
Category:
Descriptive Report
Topic:
Ambulatory Care
Co-Author(s):
Madison A. Barrier, Alley B. Minton, Samantha M. Sharpe, Madison H. Wilson
Primary Author(s)
Elizabeth Martinez Delgado, PharmD